Health care has been the top issue in Congress all year, and December is shaping up to be no different. The tax reform bills working their way through Congress could mean major changes for America’s hospitals and health systems.
AHA Stat Blog
Latest
The hustle and bustle of the holiday season is a good time to think about the gift of health.
Are your hospital’s volunteers teaming up with others in your community to help the people you serve become healthier?
Every day, hospitals and health systems across the country are challenged in so many ways as you seek to care for those in your community. In the midst of these challenges, however, are incredible
The tax bill being considered in the House and Senate could lead to $25 billion in cuts to Medicare, according to the Cong
A cancer survivor is alive because doctors diagnosed her disease in time and got her the treatment she needed immediately.
Our freedoms were earned – and continue to be protected every single day – by the service of our nation’s veterans.
An article in today’s Politico suggests hospital mergers are having an adverse impact on health local markets and is leading to substandard care and higher prices.
Millions of Americans soon will be giving thanks and celebrating Thanksgiving with their friends and loved ones. America’s hospitals also are preparing, but for a different reason.
November is National Diabetes Month, and all kinds of events are planned on the local and national levels to bring attention to the burgeoning epidemic.
Millions of Americans worry about the high costs of life-saving prescription drugs.
As hospitals continue to seek new ways to improve the health of their communities, it’s more important than ever for them to partner with other organizations.
The sheer volume of regulations on the books and the scope of change required in meeting them are outstripping the hospital field’s ability to absorb them.
The statistics are staggering. Every day, over 90 Americans die from an opioid overdose.
Last week, the Administration announced that it will halt funding of the cost-sharing reduction payments, or CSRs, that benefit nearly 6 million low- and modest-income Americans who buy coverage through the Health Insurance Marketplaces.
The Pharmaceutical Research and Manufacturers of America (PhRMA) released yet another report designed to obfuscate the issue of sky-rocketing drug prices.